Cargando…

Prior use of antibiotics and immunosuppression are risk factors for fracture-related infection during the COVID-19 pandemic period: a Brazilian prospective cohort study

BACKGROUND: Little is known about the role of COVID-19 pandemic period on the epidemiology of fracture-related infection (FRI). The present study summarizes the changes in the prevalence, microbiology, and risk factors of FRI during this period. METHODS: A prospective single-center cohort study asse...

Descripción completa

Detalles Bibliográficos
Autores principales: Santos, Eduardo Cezar, Prebianchi, Stefânia, Santos, Ingrid Nayara, Kurihara, Mariana Neri, Dell’Aquila, Adriana, Finelli, Carlos, dos Reis, Fernando Baldy, Salles, Mauro José
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9166157/
https://www.ncbi.nlm.nih.gov/pubmed/35658853
http://dx.doi.org/10.1186/s12891-022-05493-5
_version_ 1784720544011124736
author Santos, Eduardo Cezar
Prebianchi, Stefânia
Santos, Ingrid Nayara
Kurihara, Mariana Neri
Dell’Aquila, Adriana
Finelli, Carlos
dos Reis, Fernando Baldy
Salles, Mauro José
author_facet Santos, Eduardo Cezar
Prebianchi, Stefânia
Santos, Ingrid Nayara
Kurihara, Mariana Neri
Dell’Aquila, Adriana
Finelli, Carlos
dos Reis, Fernando Baldy
Salles, Mauro José
author_sort Santos, Eduardo Cezar
collection PubMed
description BACKGROUND: Little is known about the role of COVID-19 pandemic period on the epidemiology of fracture-related infection (FRI). The present study summarizes the changes in the prevalence, microbiology, and risk factors of FRI during this period. METHODS: A prospective single-center cohort study assessed in the setting of COVID-19 pandemic (2020–2021), clinical, microbiological aspects, and independent risk factors (RF) of FRI. RFs were estimated by bivariate and multivariable analyses using prevalence ratio (PR) with significance at P < 0.05. Kaplan–Meier analysis was performed to evaluate treatment outcomes. RESULTS: Overall, 132 patients were analyzed, with patients with age over 65 years accounting 65.1%. FRI was diagnosed in 21(15.9%) patients. Independent RFs for FRI were recent and preoperative use of systemic antibiotics (PR: 7.0, 95% confidence interval (95% CI): 2.2 – 22.4, p = 0.001) and cancer (PR: 9.8, 95% CI: 2.0 – 48.8, p = 0.005). Cultures yielded Gram-negative bacteria in 77.8%, 33.3% were MDR. CONCLUSIONS: We found higher rates of FRI, predominating in the elderly with closed femoral fractures during the COVID-19 pandemic. Prior use of antibiotics and immunosuppression conditions were independent factor for FRI. Our outcomes provide evidence to avoid the empirical use of antibiotics prior to surgery for fracture stabilization. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12891-022-05493-5.
format Online
Article
Text
id pubmed-9166157
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-91661572022-06-05 Prior use of antibiotics and immunosuppression are risk factors for fracture-related infection during the COVID-19 pandemic period: a Brazilian prospective cohort study Santos, Eduardo Cezar Prebianchi, Stefânia Santos, Ingrid Nayara Kurihara, Mariana Neri Dell’Aquila, Adriana Finelli, Carlos dos Reis, Fernando Baldy Salles, Mauro José BMC Musculoskelet Disord Research BACKGROUND: Little is known about the role of COVID-19 pandemic period on the epidemiology of fracture-related infection (FRI). The present study summarizes the changes in the prevalence, microbiology, and risk factors of FRI during this period. METHODS: A prospective single-center cohort study assessed in the setting of COVID-19 pandemic (2020–2021), clinical, microbiological aspects, and independent risk factors (RF) of FRI. RFs were estimated by bivariate and multivariable analyses using prevalence ratio (PR) with significance at P < 0.05. Kaplan–Meier analysis was performed to evaluate treatment outcomes. RESULTS: Overall, 132 patients were analyzed, with patients with age over 65 years accounting 65.1%. FRI was diagnosed in 21(15.9%) patients. Independent RFs for FRI were recent and preoperative use of systemic antibiotics (PR: 7.0, 95% confidence interval (95% CI): 2.2 – 22.4, p = 0.001) and cancer (PR: 9.8, 95% CI: 2.0 – 48.8, p = 0.005). Cultures yielded Gram-negative bacteria in 77.8%, 33.3% were MDR. CONCLUSIONS: We found higher rates of FRI, predominating in the elderly with closed femoral fractures during the COVID-19 pandemic. Prior use of antibiotics and immunosuppression conditions were independent factor for FRI. Our outcomes provide evidence to avoid the empirical use of antibiotics prior to surgery for fracture stabilization. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12891-022-05493-5. BioMed Central 2022-06-04 /pmc/articles/PMC9166157/ /pubmed/35658853 http://dx.doi.org/10.1186/s12891-022-05493-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Santos, Eduardo Cezar
Prebianchi, Stefânia
Santos, Ingrid Nayara
Kurihara, Mariana Neri
Dell’Aquila, Adriana
Finelli, Carlos
dos Reis, Fernando Baldy
Salles, Mauro José
Prior use of antibiotics and immunosuppression are risk factors for fracture-related infection during the COVID-19 pandemic period: a Brazilian prospective cohort study
title Prior use of antibiotics and immunosuppression are risk factors for fracture-related infection during the COVID-19 pandemic period: a Brazilian prospective cohort study
title_full Prior use of antibiotics and immunosuppression are risk factors for fracture-related infection during the COVID-19 pandemic period: a Brazilian prospective cohort study
title_fullStr Prior use of antibiotics and immunosuppression are risk factors for fracture-related infection during the COVID-19 pandemic period: a Brazilian prospective cohort study
title_full_unstemmed Prior use of antibiotics and immunosuppression are risk factors for fracture-related infection during the COVID-19 pandemic period: a Brazilian prospective cohort study
title_short Prior use of antibiotics and immunosuppression are risk factors for fracture-related infection during the COVID-19 pandemic period: a Brazilian prospective cohort study
title_sort prior use of antibiotics and immunosuppression are risk factors for fracture-related infection during the covid-19 pandemic period: a brazilian prospective cohort study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9166157/
https://www.ncbi.nlm.nih.gov/pubmed/35658853
http://dx.doi.org/10.1186/s12891-022-05493-5
work_keys_str_mv AT santoseduardocezar prioruseofantibioticsandimmunosuppressionareriskfactorsforfracturerelatedinfectionduringthecovid19pandemicperiodabrazilianprospectivecohortstudy
AT prebianchistefania prioruseofantibioticsandimmunosuppressionareriskfactorsforfracturerelatedinfectionduringthecovid19pandemicperiodabrazilianprospectivecohortstudy
AT santosingridnayara prioruseofantibioticsandimmunosuppressionareriskfactorsforfracturerelatedinfectionduringthecovid19pandemicperiodabrazilianprospectivecohortstudy
AT kuriharamariananeri prioruseofantibioticsandimmunosuppressionareriskfactorsforfracturerelatedinfectionduringthecovid19pandemicperiodabrazilianprospectivecohortstudy
AT dellaquilaadriana prioruseofantibioticsandimmunosuppressionareriskfactorsforfracturerelatedinfectionduringthecovid19pandemicperiodabrazilianprospectivecohortstudy
AT finellicarlos prioruseofantibioticsandimmunosuppressionareriskfactorsforfracturerelatedinfectionduringthecovid19pandemicperiodabrazilianprospectivecohortstudy
AT dosreisfernandobaldy prioruseofantibioticsandimmunosuppressionareriskfactorsforfracturerelatedinfectionduringthecovid19pandemicperiodabrazilianprospectivecohortstudy
AT sallesmaurojose prioruseofantibioticsandimmunosuppressionareriskfactorsforfracturerelatedinfectionduringthecovid19pandemicperiodabrazilianprospectivecohortstudy